HOME >> BIOLOGY >> NEWS
Structure of cog at the hub of metabolism reveals anti-ageing function

olecules, like glucose, to release energy for use in the body. Found deep inside most human cells in tiny power plants called mitochondria, succinate dehydrogenase plays a key part in this process when oxygen is present. Embedded in the inner membrane of the mitochondria, the enzyme is involved in a system that transfers energy using electrons.

Using the latest X-ray crystallography techniques, Imperial PhD student, Rob Horsfield solved the structure of succinate dehydrogenase. Researchers from the UK, Sweden, the United States and Japan were then able to probe the three-dimensional structure of the protein, to examine how the enzyme releases energy by breaking down a derivative of glucose, succinate, to a smaller molecule fumarate.

To determine what factors influence free radical production, the team compared the structure of succinate dehydrogenase to a similar enzyme, fumarate reductase.

"Until now, it has been unclear why cells preferentially use succinate dehydrogenase in the presence of oxygen and fumarate reductase in its absence to perform the same job," explains Professor Iwata.

"Previous research indicates that fumarate reductase produces 120 times more superoxide than succinate dehydrogenase in the presence of oxygen. Now, we can see why subtle differences between the two structures means that when energy is released from succinate it is not transferred to the next stage of respiration but leaks out, leading to superoxide production."

Professor Iwata added: "Succinate dehydrogenase's structure is far more efficient at handing that energy onto the next stage of respiration. It seems likely that there has been evolutionary pressure for organisms to pick succinate dehydrogenase to limit the damage inflicted on cells by superoxide production."


'"/>

Contact: Judith H. Moore
j.h.moore@imperial.ac.uk
44-207-594-6702
Imperial College London
30-Jan-2003


Page: 1 2

Related biology news :

1. Structure solved at Scripps shows how one human protein reduces potency of chemotherapy
2. Structure solved by Scripps scientists shows one way that body controls gene expression
3. Structure of a Nobel-prize winning molecule: Aquaporin
4. Structure of HIV-neutralizing antibody solved
5. Structure of key breast cancer receptor determined
6. Structure of pain-modulating enzyme described by scientists at the Scripps Research Institute
7. Structure reveals details of cells cargo-carriers
8. Structure of key receptor unlocked; Related proteins will fall like dominoes
9. New Science Press launches Proteins: From Sequence to Structure
10. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment
11. Structure of key protein involved in cancer, osteoporosis and foot-and-mouth disease finally solved

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... ... Dr. Julie Reck of Veterinary Medical Center of Fort Mill has recently begun ... patient, her own geriatric Australian Shepherd, Simon, was treated in June 2019 for osteoarthritis in ... his body was weak, and he struggled to play fetch and other games with his ...
(Date:8/6/2019)... ... August 06, 2019 , ... VetStem Biopharma has ... GMP manufacturing experience. In November it spun out a human regenerative medicine ... and one of the first cGMP cell manufacturing facilities in California , ...
(Date:8/6/2019)... ... August 06, 2019 , ... The demand for plant-based ... in particular quickly entered the limelight – meat alternatives. Yet, to make these ... emulsifying ingredient such as methyl cellulose. This ingredient is highly synthetic. Having a ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements ... an upcoming episode, scheduled to broadcast 4Q/2019. Check your local listings for more ... educate viewers about how its technology facilitates laboratories to improve efficiency and quality ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Clinic, a national leader in opioid treatment, announced today they are partnering to ... , Mytonomy recently deployed its virtual care platform at the Mayo Clinic to ...
(Date:6/11/2019)... N.C. (PRWEB) , ... June 11, 2019 , ... ... extracellular vesicles derived from human mesenchymal stem cells (MSC-EV) are able to incorporate ... cloning ability. In a test on mice, MSC-EVs also increased the cells’ ability ...
(Date:5/31/2019)... ... ... For many years, the primary forms of cancer treatment have been chemotherapy, ... immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR T) cell ... as “CARs”. The CAR enables the final product to produce chemicals in the hopes ...
Breaking Biology Technology:
Cached News: